An improved prognosis and a more favourable stage of the tumour in patients with invasive breast carcinoma following the introduction of the breast cancer screening programme in Tilburg;Betere prognose en gunstiger tumorstadium bij patiënten met invasief mammacarcinoom na de introductie van het bevolkingsonderzoek op borstkanker in Tilburg

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 8, 2004, Pages 378-382

  Ernst, M F ^a,b   Voogd, A C ^a,d,e   Coebergh, J W W ^a,c   Roukema, J A ^a,c  

^a CPRLab   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c The Netherlands   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EARLY CANCER; FEMALE; HUMAN; INVASIVE BREAST CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NETHERLANDS; PARTIAL MASTECTOMY; POPULATION RESEARCH; PROGNOSIS;

EID: 1342323979     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Garne JP, Aspegren K, Balldin G, Ranstam J. Increasing incidence of and declining mortality from breast carcinoma. Trends in Malmö, Sweden, 1961-1992. Cancer 1997;79:69-74.
2. Nab HW, Voogd AC, Crommelin MA, Kluck HM, Heijden LH van der, Coebergh JWW. Breast cancer in the southeastern Netherlands, 1960-1989: trends in incidence and mortality. Eur J Cancer 1993;29A:1557-9.
3. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 2000;321:665-9.
4. Levi F, Lucchini F, Negri E, la Vecchia C. The fall in breast cancer mortality in Europe. Eur J Cancer 2001;37:1409-12.
5. Moody-Ayers SY, Wells CK, Feinstein AR. 'Benign' tumors and 'early detection' in mammography-screened patients of a natural cohort with breast cancer. Arch Intern Med 2000;160:1109-15.
6. Sant M, Capocaccia R, Verdecchia A, Esteve J, Gatta G, Micheli A, et al. Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. Int J Cancer 1998;77:679-83.
7. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19.
8. Otto SJ, Fracheboud J, Looman CWN, Broeders MJ, Boer R, Hendriks JH, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361:1411-7.
9. Fracheboud J, Koning HJ de, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 1999;81:912-7.
10. Rijke JM de, Schouten LJ, Schreutelkamp JL, Jochem I, Verbeek AL. A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, the Netherlands. J Med Screen 2000;7:19-23.
11. Porter PL, el-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 1999;91:2020-8.
12. Cowan WK, Angus B, Gray JC, Lunt LG, al-Tamimi SR. A study of interval breast cancer within the NHS breast screening programme. J Clin Pathol 2000;53:140-6.
13. Brekelmans CT, Peeters PH, Deurenberg JJ, Collette HJ. Survival in interval breast cancer in the DOM screening programme. Eur J Cancer 1995;31A:1830-5.
14. Ernst MF, Voogd AC, Coebergh JWW, Repelaer van Driel OJ, Roukema JA. The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: a population-based study in Southeast Netherlands. Eur J Cancer 2001;37:2435-40.
15. Voogd AC, Louwman WJ, Coebergh JWW, Vreugdenhil G. Gevolgen op ziekenhuisniveau van de nieuwe richtlijnen voor adjuvante systemische behandeling bij mammacarcinoom. Ned Tijdschr Geneeskd 2000;144:1572-4.